Clinical Trial Update: A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) [Phase 2]

View source ↗

Summary

Phase 2 trial update for GSK3228836 in chronic hepatitis B has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GSK3228836

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2023-05-16